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A B S T R A C T
Autophagy has been shown to be stimulated in advanced atherosclerotic plaques by metabolic stress, in-
flammation and oxidized lipids. The lack of published studies addressing the potential stimulation of pro-sur-
vival autophagy by oxysterols, a family of cholesterol oxidation products, has prompted our study. Thus, the goal
of the current study is to elucidate the molecular mechanism of the autophagy induced by 27-hydroxycholesterol
(27-OH), that is one of the most abundant oxysterols in advanced atherosclerotic lesions, and to assess whether
the pro-oxidant effect of the oxysterol is involved in the given response. Here we showed that 27-OH, in a low
micromolar range, activates a pro-survival autophagic response in terms of increased LC3 II/LC3 I ratio and
Beclin 1, that depends on the up-regulation of extracellular signal-regulated kinase (ERK) and phosphoinositide
3-kinase (PI3K)/Akt pathways as a potential result of an intracellular reactive oxygen species increase provoked
by the oxysterol in human promonocytic U937 cells. Moreover, 27-OH induced autophagy is dependent on the
relation between nuclear factor erythroid 2 p45-related factor 2 (Nrf2)-dependent antioxidant response and p62.
The data obtained highlight the involvement of cholesterol oxidation products in the pathogenesis of oxidative
stress related chronic diseases like atherosclerosis. Therefore, deeply understanding the complex mechanism and
generating synthetic or natural molecules targeting this survival mechanism might be very promising tools in the
prevention of such diseases.
1. Introduction
Cholesterol oxidation products have been shown to modulate sev-
eral signaling pathways, thus biochemical effects of these compounds
are varied from their strong pro-inflammatory, pro-apoptotic and pro-
fibrogenic properties [1]. Among them, scientist are increasingly
drawing attention to oxysterols, a family of 27-carbon molecules ori-
ginated from cholesterol oxidation, that appear significantly involved in
the progression of inflammatory-based chronic pathologies, such as
atherosclerosis, neurodegenerative diseases, diabetes mellitus and
cancer [2–5]. The oxysterol 27-hydroxycholesterol (27-OH), one of the
most represented oxysterols in the peripheral blood of healthy in-
dividuals, is enzymatically produced by 27-hydroxylase (CYP27A1) [6].
Nowadays, 27-OH has been shown to act as a competitive ligand for
liver X receptor [7,8] and a selective estrogen receptor [9], thus it
appears to modulate intracellular signals related to cancer cell growth
and atherosclerosis progression [10,11].
It is now well accepted that certain oxysterols, including 27-OH,
modulate not only the pro-apoptotic and pro-inflammatory response
but also cell survival pathways in various cell types [12,13]. In parti-
cular, they trigger signaling transduction pathways either pro-apoptotic
or anti-apoptotic, depending on cell types, oxysterol concentration and
exposure time [14,15]. Moreover, this dual effect exerted by oxysterols
appeared to be modulated via a mechanism involving reactive oxygen
species (ROS) [16–18]. Very recently, our group provided a clear evi-
dence of modulation of survival signaling with a low micromolar
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concentration (10 µM) of 27-OH in U937 human promonocytic cells
through extracellular signal-regulated kinase (ERK) and the phosphoi-
nositide 3-kinase (PI3K)/Akt pathways [19]. Moreover, the marked up-
regulation of the ERK/Akt axis was, in turn, able to quench the oxi-
dative imbalance exerted by the oxysterol itself through the induction
of nuclear factor erythroid 2 p45-related factor 2 (Nrf2) antioxidant
defense system.[20]. Namely, a significant induction of Nrf2 and
synthesis of Nrf2 target enzymes, including heme oxygenase-1 (HO-1)
and NAD(P)H:quinone oxireductase, appeared to be dependent on the
activation of ERK and Akt pathways and fundamentally responsible for
the observed oxysterol-induced pro-survival response, at low con-
centration (10 µM), in promonocytic cells. However, relatively high
concentration of 27-OH (100 µM) did not exert any survival effect in
U937 cells while a constant pro-oxidant effect induced by the oxysterol
was demonstrated.
Macroautophagy (generally referred to as autophagy) breaks down
protein aggregates and damaged organelles in order to maintenance
cellular recycling during stress conditions. Autophagy is a multi-step
physiological process that starts with sequestration of the cell material
to be eliminated within double-membrane vesicles, known as autop-
hagosomes; then, these autophagosomes fuse with lysosomes for sub-
sequent degradation [21]. It is generally accepted that even if autop-
hagy serves as a cell survival mechanism, under certain stress
conditions its excessive enhancement may lead to cell death [22]. Ac-
cumulating data point to a critical role for autophagy at intersection of
life and death of cancer cells, while a cross-talk exists between autop-
hagy and classical apoptosis. It is now well established that autophagy
appears regulated by ROS [23]. Hence, the redox regulation of autop-
hagy has been observed in various pathological conditions but how
autophagy induction affects these processes remains incompletely un-
derstood. Recent studies have highlighted the important role of oxi-
dized lipids, including 4-hydroxy-trans-2-nonenal (HNE) and oxy-
sterols, in the regulation of autophagy in atherosclerosis. Additional
work is needed to elucidate the up-stream signal transduction pathways
responsible for the effects of oxysterols on autophagy modulation
[24,25].
The Kelch-like ECH-associated protein 1 (Keap1)-Nrf2 signaling
pathway functions as one of the key regulator of the cellular defense
system against oxidative stress [26]. Nrf2 is a redox-sensitive tran-
scription factor, that is sequestered in the cytoplam by binding to
Keap1; however, under oxidative stress, Nrf2 dissociates from Keap1
and translocates into the nucleus where it binds to antioxidant response
element (ARE) sequences, codifying for antioxidant enzymes [27,28]. A
growing body of evidence has demonstrated the interplay between the
Keap1/Nrf2 system and selective autophagy mainly relied on the p62/
SQSTM1 protein (hereafter referred to as p62), which is an autophagy
substrate and also a receptor for degradation of ubiquitinated protein
aggregates, in turn associating with both LC3 and ubiquitin [29,30].
Evidence suggests that p62 interacts with the Nrf2-binding site of Keap1
and competes with Nrf2 for the interaction with Keap1 which results in
transcriptional activation of Nrf2 and its target gene expression
[30,31]. Moreover, Nrf2 regulates p62 expression by binding directly to
ARE binding motif of the p62 promoter, suggesting a positive feedback
loop between these two proteins [32].
To investigate in depth the molecular mechanism of Nrf2-modu-
lated 27-OH induced survival signaling [19,20], in the present paper we
aimed to elucidate the potential stimulation of pro-survival autophagy
by low micromolar concentration of 27-OH and to explore the re-
levance between Nrf2 pathway and selective autophagy, with regard to
the modulation of p62 protein. The obtained data showed that 27-OH
up-regulated autophagic proteins including LC3 and Beclin 1 in a ROS-
dependent manner in human promonocytic cells. Indeed, autophagy
seems involved in 27-OH-induced Nrf2 modulated survival signaling.
2. Materials and methods
2.1. Cell culture and treatments
The human promonocytic cell line U937 was cultured in RPMI-1640
medium supplemented with 10% fetal bovine serum (FBS), 2 mM glu-
tamine, 100 U/ml penicillin/streptomycin (Pan Biotech GmbH,
Aidenbach, Germany) at 37 °C with 5% CO2. For treatments, cells were
dispensed at 1× 106/ml and made quiescent through overnight in-
cubation in serum-free medium; they were then placed in RPMI-1640
medium with 2% FBS and treated with 27-OH (Steraloids Inc., Newport,
RI, USA) dissolved in ethanol. In some experiments, cells were pre-
treated with PD98059 (40 μM), a selective inhibitor of mitogen-acti-
vated protein kinase ERK kinase 1/2 (MEK1/2), or with LY294002
(25 μM), a selective inhibitor of PI3K (Calbiochem, EMD Millipore
Corporation, Billerico, MA, USA), or with N-acetylcysteine (NAC)
(100 μM), an antioxidant compound (Sigma, Darmstadt, Germany), or
with diphenyleneiodonium chloride (DPI) (50 μM), an inhibitor of
NADPH oxidase (Sigma, St. Louis, MO, USA), or with Bafilomycin A1
(10 nM), an inhibitor of late phase of autophagy (Sigma) or with Torin 1
(250 nM), an inhibitor of mammalian target of rapamycin 1/2
(mTOR1/2) (Tocris Bioscience, UK). Moreover, some cells were in-
cubated with an antibody against Nrf2 (Santa Cruz Biotechnology Inc.,
Denver, CO, USA). Final concentrations and incubation times for all
experiments are reported in the figure legends.
2.2. Protein extraction and immunoblotting
The human promonocytic U937 cells were treated as indicated and
harvested by centrifugation at 300g for 30 s. Following resuspension in
1ml of ice-cold PBS and transfer to 1.5 ml microfuge tubes, cells were
spun at 2640g for 30 s. The pellet was lysed by incubation for 30min in
200 μl of cold cell lysis buffer containing 50mM Tris/HCl (pH 8),
150mM NaCl, 1 mM phenylmethanesulfonyl, protease and phosphatase
inhibitor cocktails (Roche, F. Hoffman-La Roche Ltd., Basel,
Switzerland), and 1% Nonidet P-40 (v/v) (Sigma). After centrifugation
at 2640g for 10min, the supernatant containing the total protein extract
was removed and stored at − 80 °C. Protein concentrations were de-
termined by the BSA protein assay (Bio-Rad, Munich, Germany).
Following the lysis of cells, 30 μg of whole cell lysates were mixed
with loading buffer (4% SDS, 20% glycerol, 10% 2-mercaptoethanol,
0.004% bromophenol blue, 0.125M Tris/HCl pH:6.8) (Sigma), dena-
tured at 95 °C for 5min, and separated on 10–15% SDS-polyacrylamide
gel electrophoresis (PAGE), followed by blotting onto polyvinylidene
difluoride (PVDF) membranes (Amersham Pharmacia Biotech,
Freiburg, Germany). The membranes were blocked with 5% blocking
reagent (Amersham) in PBS-Tween 20 and incubated with appropriate
primary antibodies (anti-Nrf2, anti-Beclin 1, anti-p62, anti-LC3I and
anti-LC3 II, and anti-β-actin) and horseradish peroxidase-conjugated
secondary antibodies (Cell Signaling Technology Inc., Beverly, MA) in
5% blocking reagent. For some experiments, to analyze the levels of
p62 50 μg of total proteins were immunoprecipitated with 4 μl of anti-
p62 primary antibody (Cell Signaling Technology Inc.), purified on
Protein A Sepharose resin (GE Healthcare Europe, Milan, Italy), sepa-
rated on 10% PAGE, and then electroblotted as described above. The
membranes were immunoblotted overnight at 4 °C with an anti-p62
(1:1500), and then with an anti-rabbit secondary antibody (1:2000)
(Cell Signaling Technology Inc.). After the required washes with PBS
1×-Tween 20, proteins were finally analyzed using an enhanced che-
miluminescence detection system and exposed to Hyperfilm-ECL
(Amersham Pharmacia Biotech). Immunoblots were visualized using X-
ray film and quantified by densitometry using ImageJ software. All
experiments were repeated at least three times.
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2.3. siRNA transfection
Small interfering RNA (siRNA) was used for transient gene knock-
down studies. The siRNAs used were Hs_BECN1_1 (Beclin 1), NFE2L2
s9493 (Nrf2), and siRNA #1 for the negative control (scramble siRNA)
(Life Technologies, Thermo Fisher Scientific, Monza, Italy). Negative
control corresponds to a siRNA with nonspecific sequence. Transfection
of Beclin 1 and Nrf-2 specific siRNAs and scramble siRNAs were per-
formed following the manufacturer's instructions. Briefly, 50 nM of
siRNAs were mixed with 25 μl of transfection reagent solution (NeoFX,
Life Technologies) and left at room temperature for 10min in RPMI
medium with 1% FBS and without antibiotics. After 48 h of reverse
transfection, cells were harvested, incubated with 27-OH and assays
were carried out to evaluate cell death, protein levels and autophagy
induction. The transfection efficiency validated by quantitative reverse
transcription-polymerase chain reaction (RT-PCR), was approximately
71% for Beclin 1 and Nrf2 (data not shown).
2.4. Cell death, viability and proliferation assay
Apoptotic cell death was determined by an Annexin V affinity assay.
U937 cells seeded in 12-well plates were treated as indicated, trans-
ferred to flow cytometry tubes, and harvested by centrifugation at 300 g
for 5min. The cells were then resuspended in 1ml of cold PBS and
again centrifuged at 300g for 5min. After removal of supernatant, the
cells were incubated in Annexin V buffer (140mM Hepes, 10 mM NaCl,
2.5 mM CaCl2, pH 7.4) (Sigma) containing 1% (v/v) Annexin V con-
jugated with fluorescein isothiocyanate fluorochrome (FITC) (Alexis
Biochemicals, Enzo Life Sciences, Inc., Farmingdale, NY) for 15min in
the dark. Cells were analyzed by FACS (FACS Canto, Becton Dickinson,
Franklin Lakes, NJ).
In order to detect cell viability and proliferation, exposure to 27-OH
was determined by WST-1 (Cell Proliferation Reagent) following the
manufacturer's instructions (Roche Diagnostics, GmbH, Penzberg,
Germany). Briefly, cells in 96-well plates were treated as indicated and
10 μl of WST-1 reagent was added to each well, after which the plates
were incubated for 4 h at 37 °C. Absorbance was measured with a mi-
crotiter plate reader (Bio-Rad, CA, USA) at a test wavelength of 450 nm
and a reference wavelength of 655 nm.
2.5. Statistical analyses
All the illustrated results represent one of at least three independent
experiments with similar outcomes. All data are presented as
means ± standard deviation (S.D.). Statistical significance of the re-
sults was analyzed by the Student's t-tail test and *P < 0.05,
**P < 0.01 and ***P < 0.001 were considered statistically sig-
nificant.
3. Results
3.1. Induction of autophagy by low concentrations of 27-OH in U937 cells
To determine whether autophagy could be induced by low con-
centration (10 μM) of 27-OH in U937 cells, we investigated the protein
levels of some autophagy-specific markers: LC3, Beclin 1 and p62 by
immunoblot analysis at different time points. As shown in Fig. 1A, the
single addition of 10 μM 27-OH to U937 cells did not show any sig-
nificant modulation of both the total cellular levels of Beclin 1 and the
ratio of LC3 II/LC3 I between 3 and 12 h. Consistently, p62 protein
expression was significantly increased in response to low dose of 27-OH
in a time-dependent manner. Furthermore, at different time points (24,
48 and 72 h), we observed that LC3 II/LC3 I ratio and Beclin 1 were
significantly increased especially after 48 h cell treatment (Fig. 1B).
Moreover, the down-regulation of p62 protein levels demonstrated an
increasing autophagic flux in promonocytic cells starting from 24 h cell
treatment.
We further investigated the autophagic markers between 4 days and
1 week: 27-OH did not stimulate but, on the contrary, it down-regulated
LC3 II/LC3 I ratio and the total levels of Beclin 1, while p62 protein
levels were significantly up-regulated till 1 week (Supplementary
Fig. 1). These results demonstrated that a low dose of 27-OH promoted
cellular autophagic process in U937 cells only between 24 and 72 h. In
our previous report [19], in the time frame corresponding to the pro-
apoptotic effect of 27-OH, i.e. between 4 days and 1 week after cell
treatment, autophagy induction was down-regulated. This finding
suggest that the autophagic response may protect cells against apop-
tosis, thus favoring cell survival.
3.2. Impact of ERK and PI3K/Akt signaling on 27-OH induced autophagy
Previous studies showed that ERK and Akt play role in autophagy
regulation [33–36]. To investigate whether ERK and PI3K/Akt sig-
naling pathways were involved in 27-OH-mediated autophagy in U937
cells, a series of immunoblotting experiments employing selective in-
hibitors of these kinases were performed. Firstly, U937 cell aliquots
were pre-treated with the MEK/ERK inhibitor PD98059 (40 μM) or with
the PI3K/Akt inhibitor LY294002 (25 μM) in the presence of 10 μM 27-
OH. As the Fig. 2A shows, 40 μM PD98059 significantly reduced LC3 II/
LC3 I ratio and Beclin 1 protein levels after 72 h treatment with 27-OH.
As expected, cell pre-incubation with 25 μM LY294002 effectively
prevented the 27-OH-mediated up-regulation of LC3 II levels and Beclin
1 protein levels. Further, as reported in Fig. 2B, the effect of these se-
lective inhibitors was also determined for p62 protein after 12 h treat-
ment with 27-OH. It has been clearly demonstrated that pre-incubation
with ERK/Akt inhibitors resulted in a net prevention of the 27-OH-in-
duced p62 expression observed after 12 h treatment with the oxysterol.
Taken together, these data suggest that ERK and PI3K/Akt survival
pathways are involved in 27-OH induced autophagy and stimulate p62
synthesis in U937 promonocytic cells.
3.3. Involvement of autophagy in 27-OH induced survival response
As we demonstrated that 27-OH-induced redox-modulated survival
signaling [19], we further explored the role of autophagy in delaying
the apoptotic cell death.
To ascertain whether autophagy is involved in 27-OH induced sur-
vival response in U937 cells, autophagy inhibition related experiments
were carried out. Flow cytometric analysis showed that in aliquots of
U937 cells pre-incubated with a non cytotoxic concentration (10 nM) of
Bafilomycin A1, a well-known inhibitor of autophagosomal lysosome
degradation, the number of Annexin V positive cells markedly increased
compared to cells treated with 27-OH alone (Fig. 3A). Indeed, the
percentage of apoptotic cells was about 11% after 48 h treatment with
10 nM Bafilomycin A1 plus 10 μM 27-OH, which is approximately the
percentage of Annexin V positive cells induced by 27-OH alone after
72 h cell treatment.
To validate these observations, the actual role of autophagy in the
27-OH-mediated survival was further studied by knocking-down Beclin
1 expression. The expression of Beclin 1 protein was remarkably sup-
pressed in U937 cells transfected with Beclin 1 siRNA when compared
to control group (data not shown). Accordingly, cell transfection with
specific Beclin 1 siRNA determined a sharp increase in the number of
apoptotic cells after 24 h incubation with 10 μM 27-OH (Fig. 3B).
Namely, the percentage of apoptotic cells nearly doubled from 17% in
the absence of siRNA to 32% in the presence of Beclin 1 siRNA. In
addition to these results, using Torin 1, mTOR inhibitor at noncytotoxic
concentration of 250 nM (Supplementary Fig. 2) we observed sig-
nificant induction of cell viability and proliferation versus the control
after 3 h cell treatment as measured by WST-1 assay (Supplementary
Fig. 3). These results support that prevention of autophagy-dependent
survival signaling accelerated the apoptosis induced by the low
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micromolar concentration of the oxysterol.
3.4. Dependence of 27-OH induced autophagy on the intracellular rise of
ROS
Accumulated evidence shows that ROS modulate the autophagy
pathways and the interplay between ROS and autophagy signaling
plays a role in diverse pathological conditions [37,38]. Based on the
above results and literature, we wondered whether 27-OH induced
autophagy and p62 up-regulation could be mediated by intracellular
generation of ROS. In our previous report we showed an increase of
ROS cellular levels operated by 27-OH through the derangement of
mitochondrial membrane potential and activation of NADPH oxidase
type 2 (Nox-2) [19]. In the light of these findings, to investigate whe-
ther Nox-2 sourced ROS could play a critical role in mediating 27-OH-
induced autophagy, U937 cells were pre-treated with the antioxidant
Fig. 1. 27-hydroxycholesterol (27-OH) induces autophagy in U937 cells. Protein levels of LC3 I and LC3 II, Beclin 1 and p62 in U937 cells treated with 10 μM 27-OH
for 3, 6 and 12 h (A) and for 24, 48 and 72 h (B) were analyzed by Western blotting. Untreated cells were taken as controls. One blot representative of three
experiments is shown. Histograms represent the mean values ± S.D. of three independent experiments; LC3 I, LC3 II, Beclin 1 and p62 band intensities were
quantified using ImageJ software; densitometric measurements were normalized against the corresponding actin levels and expressed as percentage of control value;
*p < 0.05, **p < 0.01 and ***p < 0.001 vs. control group.
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NAC or DPI, a NADPH oxidase inhibitor, prior to 6 h challenge with
10 μM 27-OH, and p62 protein levels were analyzed by immunoblotting
(Fig. 4A,B). We found that 27-OH-dependent increase of p62 protein
levels was significantly inhibited by 100 μM NAC. Moreover, as shown
in Fig. 4B, cell pre-treatment (45min) with 50 μM DPI was able to
nearly suppress the induction of p62 after 6 h 27-OH treatment. Fur-
ther, we examined the effect of ROS up-regulation on LC3 II/LC3 I ratio
and cell Beclin 1 content. As shown in Fig. 4C, pre-incubation of cells
Fig. 2. Inhibition of MEK/ERK and PI3K/Akt signaling pathways down-regulates autophagy. U937 cells were either treated with 10 μM 27-hydroxycholesterol (27-
OH) alone or pre-incubated with PD98059 (40 μM) or LY294002 (25 μM) 45min before 27-OH treatment. Untreated cells were taken as controls. LC3 I and LC3 II,
Beclin 1 (A) and p62 (B) protein levels were analyzed by Western blotting. One blot representative of three experiments is shown. Histograms represent the mean
values ± S.D. of three independent experiments; LC3 I, LC3 II, Beclin 1 and p62 band intensities were quantified using ImageJ software; densitometric measure-
ments were normalized against the corresponding actin levels and expressed as percentage of control value; *p < 0.05 and **p < 0.01 vs. control group;
#p < 0.05 and ##p < 0.01vs. 27-OH.
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with the antioxidant NAC partially prevented 27-OH-dependent in-
crease of LC3 II accumulation and total Beclin 1 after 72 h oxysterol
treatment.
3.5. Impact of autophagy on 27-OH induced p62 and Nrf2 activation
Recently, several studies suggest that Nrf2 pathway protects cells
from oxidative stress via the induction of autophagy [39,40]. Note-
worthy, induction of autophagic adaptor p62 by oxidative stress is
mediated by Nrf2, and p62 contributes to the activation of Nrf2 through
creating a positive feed-back loop [31,32,41]. Our previous study has
ascertained that Nrf2-ARE antioxidant pathway has a crucial role in 27-
OH-induced survival signaling in human promonocytic cells to protect
cells from pro-oxidant stimuli [20].
Based on our previous findings and published reports, we in-
vestigated whether autophagy contributes to 27-OH exerted induction
of Nrf2 in U937 promonocytic cells. Firstly, U937 cells were pre-treated
with the mTOR inhibitor Torin 1 (250 nM) in the presence or absence of
10 μM 27-OH. In order to examine whether 27-OH-mediated p62 ex-
pression would be affected by addition of Torin 1 which can induce
autophagy, the Western blotting was utilized (Fig. 5A). The obtained
results revealed that induction of autophagy by Torin 1 in oxysterol-
treated cells afforded to prevent 27-OH induced up-regulation of total
cell level of p62. Statistical analysis of data obtained after 6 h treatment
showed that p62 synthesis was almost halved in Torin 1 plus 27-OH
treated cells in comparison to cells treated with 27-OH alone. Further,
as shown in Fig. 5B, induction of autophagy signaling with Torin 1
markedly prevented the 27-OH-mediated up-regulation of Nrf2 protein
content, as monitored after 6 h oxysterol treatment. Statistical analysis
showed that total cell level of Nrf2 was significantly decreased in
combined treated cells as to cells treated with the oxysterol alone.
Taken together, these results suggest that the relevance of Nrf2
pathway and autophagy contributes to redox regulated 27-OH induced
survival response in U937 promonocytic cells incubated in the presence
of low micromolar amount of oxysterol.
3.6. The relation between Nrf2/p62 and autophagy modulated by 27-OH
The protein p62 directly interacts with the Nrf2- binding site of
Keap1, which results in constitutive activation of Nrf2 and conse-
quently in Nrf2 target gene expression, including antioxidant enzyme
genes [32]. Thus, up-regulation of p62 is due to autophagy dysfunction
that leads to transcriptional activation of the Nrf2. In turn, Nrf2 reg-
ulates p62 expression through direct binding to ARE binding motif of
the p62 promoter.
Based on these evidence, the potential involvement of Nrf2 in p62
regulation by 27-OH was investigated. Cells were transfected for 48 h
with Nrf2 siRNA and then incubated with 10 μM 27-OH for 6 h that, in
agreement to the data shown in Fig. 1A, is the time at which p62 is
significantly up-regulated by 27-OH. Following Nrf2 gene knock-down,
p62 protein levels are significantly lower than in cells treated with 27-
OH alone (Fig. 6A). To support this hypothesis, the activity of Nrf2 was
blocked co-treating the U937 cells with a specific antibody anti-Nrf2
and 27-OH (10 μM). Blocking Nrf2 activation negatively affects p62
synthesis (Fig. 6B).
Since activation of Nrf2 positively regulates the autophagy signaling
pathway by up-regulating its target gene HO-1 and consequently LC3
[42], an event that leads to the reduction of p62 levels as evidence that
autophagy has been activated.
Cells were incubated with anti-Nrf2 antibody and 27-OH (10 μM)
for 48 h to verify whether Nrf2 is involved in the promotion of autho-
phagy reversing the effect of 27-OH on p62 levels reported in Fig. 1B.
As expected, blocking Nrf2 with a selective antibody, the degradation of
p62 was markedly prevented (Fig. 6C). Cell incubation with the anti-
Nrf2 antibody alone did not affect the levels of p62 compared with
untreated cells (Fig. 6B,C).
4. Discussion
Oxysterols are quantitatively relevant components of oxidized low
density lipoproteins (oxLDLs) and their multifaceted biochemical
properties were well-characterized in vascular cells [2,3,17]. 27-OH is
one of the most represented oxysterols in the human circulation and
also in atherosclerotic lesions [43]. On behalf of its important role in
pathophysiology, 27-OH has been established as a good ligand of nu-
clear receptors that leads to modulate cell viability, immunological
response and metabolism [7,8]. In this relation, eliciting survival and
functional signals, modulated by 27-OH, might contribute to expand
the knowledge about the molecular mechanisms of the pathogenesis of
several oxysterol-related diseases.
Autophagy is a dynamic process in which long lived proteins and
cellular organelles are removed by autophagosomes. It has become
accepted that although autophagy has been regarded as cell survival
mechanism, under certain conditions, excessive autophagy may lead to
a non-apoptotic type of cell death [22]. Despite the increasing interest
in understanding the mechanism of autophagy, there is limited in-
formation on how cellular signaling pathways regulate this complex
process. It is now well established that autophagy is stimulated in ad-
vanced atherosclerotic plaques by inflammation and oxidized lipids
where progression of atherosclerosis is characterized by formation of
these plaques [44]. The protective role of autophagy in atherosclerosis
involves the removal of damaged organelles by autophagy in response
to mild oxidative stress which contributes to cellular recovery [45].
While the effects of autophagy on pathological processes including
Fig. 3. Inhibition of autophagy anticipates the apoptotic
effect of 27-hydroxycholesterol (27-OH). (A)
Pharmacological inhibition of autophagy: U937 cells were
either treated with 27-OH (10 μM) alone or preincubated
with Bafilomycin A1 (10 nM) 1 h before 27-OH treatment.
Untreated cells were taken as controls. (B) Molecular in-
hibition of autophagy: percentage of Annexin V-stained
cells after scramble siRNA or Beclin 1 siRNA transfection
followed by 27-OH treatment. Untreated and un-
stransfected cells were taken as controls. FACS analysis
was performed by harvesting and FITC-Annexin V staining
the cells, to analyze the effect of autophagy modulation on
cell death response. Histograms represent the mean
values ± S.D. of four independent experiments;
**p < 0.01 and ***p < 0.001 vs. untreated control
group; #p < 0.05 and ###p < 0.001 vs. 27-OH.
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atherosclerosis are complex, further studies are required to distinguish
the relation between oxysterols and autophagy.
In the current study, we examined the mechanism by which 27-OH
induces autophagy using U937 promonocytic cells. We demonstrated
that the ROS-mediated induction of autophagy by low micromolar
concentration of 27-OH is primary responsible for the observed oxy-
sterol-induced pro-survival response and stimulated expression of an-
tioxidant Nrf2. Moreover, the critical role of Nrf2 in controlling au-
tophagy via p62 in response to oxidative stress was observed. To the
best of our knowledge, this is the first demonstration of the stimulation
Fig. 4. Modulation of autophagy induction by N-acetyl cysteine (NAC) and diphenyleneiodonium chloride (DPI). Effect of NAC or DPI on 27-OH-dependent p62
induction: cells were pre-incubated (1 h) with 100 μM NAC (A) or 50 μM DPI (B) and then treated with 27-OH (10 μM) for 6 h. Effect of NAC on 27-OH-dependent
autophagy induction: cells were pre-incubated (1 h) with 100 μMNAC and then treated with 10 μM 27-OH for 72 h (C). Untreated cells were taken as controls. Protein
levels of p62, LC3 I and LC3 II, and Beclin 1 were analyzed by Western blotting. One blot representative of three experiments is shown. Histograms represent the
mean values ± S.D. of three independent experiments; LC3 I, LC3 II, Beclin 1, and p62 band intensities were quantified using ImageJ software; densitometric
measurements were normalized against the corresponding actin levels and expressed as percentage of control value *p < 0.05 and **p < 0.01 vs. control group;
#p < 0.05 vs. 27-OH.
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of pro-survival autophagy by 27-OH at low micromolar concentrations
in promonocytic cells. In consistent with our findings, Martinet et al.
showed that 7-ketocholesterol (7-K) stimulated autophagy in human
vascular smooth muscle cells (SMCs) in terms of myelin figure forma-
tion, LC3 processing and also intense protein ubiquitination [24]. In
contrast, in another study using SMCs, high concentrations of 7-K
treatment caused autophagic cell death via autophagic vesicle forma-
tion with LC3 processing. This autophagic response induced by 7-K
attenuated SMC apoptosis induced by low concentrations of lipophilic
statins by suppressing caspase activation [46]. This different outcome
of the autophagic response may be due to the relatively greater cyto-
toxicity of 7-K than 27-OH.
As summarized in Fig. 1, autophagy up-regulation in terms of Beclin
1 induction, increase of LC3 II and p62 down-regulation were observed
between 24 and 72 h of cell incubation, this coinciding with the end of
the period 27-OH caused slight reduction of cell viability and pro-
liferation as previously reported [19]. Moreover, the decrease of au-
tophagy induction, as marked by the induction of p62 between 4 up to 7
days oxysterol treatment was consistent with the interval considered
the pro-apoptotoic effect of 10 μM 27-OH was demonstrated, suggesting
that oxysterol activates cytoprotective autophagy which provides sus-
tained cellular survival (Supplementary Fig. 1).
In addition, as depicted in Fig. 3, blockade of autophagy subse-
quently enhanced the apoptosis in U937 promonocytic cells. Using
chemical and molecular approaches, Bafilomycin A1 and Beclin 1
siRNA administration respectively, we found that induction of autop-
hagy was obligatory for low concentrations of 27-OH-induced survival
response, most likely an adaptive survival strategy that recycles ag-
gregates and eliminates damaged organelles, to protect against the
apoptotic cell death. This observation is consistent with previous work
showing that 7-K induces NADPH oxidase-mediated autophagy as a
cellular protective response that extenuated endoplasmic reticulum
stress/apoptosis pathway induced by 7-K in human aortic SMCs [47].
An additional study shows that autophagy induction by 7-oxysterols,
mixed in an atheroma-relevant proportion reduced 7-oxysterols in-
duced cell death by reducing lysosomal membrane permeabilization
where induced autophagy may have a cytoprotective effect to limit
necrotic core formation in atheroma progression [48]. On the other
hand, treatment of 158 N murine oligodendrocytes with a relatively
high concentration (50 μM) of 7-K was shown to trigger a type of death
termed oxyapoptophagy with the concomitent induction of autophagy
and apoptosis [49]. Not only oxysterols but also low levels of oxLDLs,
were demonstrated to activate autophagic markers in vascular cell lines
whereas high concentrations of oxLDLs induce apoptosis by modulating
oxLDL scavenger receptor 1 [50]. It has to be pointed out that the
outcome of an autophagic response depends on oxidant concentration
and exposure time. In fact, these oxidized lipids are able to trigger pro-
survival autophagy upon treatment of cells only with low amount.
In the last years, it has been accepted that serine/threonine kinases
involving AMP-activated protein kinase (AMPK), mTOR, protein ki-
nases C (PKCs), Akt and mitogen-activated protein kinases (MAPKs),
such as ERK, p38 and c-Jun NH2-terminal kinase (JNK), have regulatory
role in various steps of autophagy [51]. Indeed, these kinases either
positively or negatively regulate autophagic response depending on the
inducer and the cellular context [15]. In a recent study it has been
shown that HNE, a lipid peroxidation-derived aldehyde, stimulated pro-
survival autophagic response interms of LC3 II formation in a JNK-de-
pendent mechanism in rat aortic SMCs [52]. Our results demonstrate
that ERK and Akt phosphorylation is required for autophagy induction
and also p62 up-regulation in 27-OH-treated U937 cells. Indeed, as
shown in Fig. 2, pharmacological inhibition of these pathways by the
MEK/ERK inhibitor PD98059 and the PI3K/Akt inhibitor LY294002
respectively, prevented LC3 II formation and decreased Beclin 1 and
p62 expression in response to oxysterol treatment. These metabolic
inhibitors were used at the relevant concentrations reported in the lit-
erature and also tested as not being cytotoxic in the experimental model
adopted [19]. Accumulating research now interest in modulating au-
tophagy for cancer therapy. Of note, MEK/ERK and PI3K/Akt pathways
are activated in several cancers and contribute to cancer progression
[53,54]. Therefore, targeting these pathways to regulate autophagy
could be a promising tool for cancer therapy to maintain autophagic
response at sufficient levels.
Accumulating data suggest that ROS trigger autophagy but, in turn,
autophagy reduces ROS levels [23]. Our results are in agreement be-
cause 27-OH mediated autophagy induction interms of LC3 II formation
and Beclin 1 protein expression was suppressed by treating the
Fig. 5. 27-Hydroxycholesterol (27-OH) induced Nrf2 in U937 cells is mediated
by autophagy. U937 cells were either treated with 27-OH (10 μM) alone or pre-
incubated with Torin 1 (250 nM) before the 27-OH treatment. Untreated cells
were taken as controls. (A) p62 and (B) Nrf2 protein levels were analyzed by
Western blotting. One blot representative of three experiments is shown.
Histograms represent the mean values ± S.D. of three independent experi-
ments; p62 and Nrf2 band intensities were quantified using ImageJ software;
densitometric measurements were normalized against the corresponding actin
levels and expressed as percentage of control value *p < 0.05 and **p < 0.01
vs. control group; #p < 0.05 and ##p < 0.01 vs. 27-OH.
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promonocytic cells with the antioxidant NAC (Fig. 4C). Consistently, 7-
K was shown to be involved in pro-survival autophagic response, spe-
cifically Beclin 1 transcription that regulated by a mitochondrial en-
zyme, proline oxidase-dependent ROS in oxLDL challenged cancer cells
[55]. Another critical observation was that cell supplementation with
either NAC or DPI prevents the induction of p62 expression by 27-OH
(Fig. 4A,B). Several recent reports establish a role for p62 in delivering
oxidized proteins to autophagosomes for the removal of these protein
aggregates [23]. Moreover, Mathew et al. indicated p62 as a new cri-
tical player in cancer showing that impairment in autophagy leads to
p62 accumulation, thereby promoting tumorigenesis [56]. Notably, a
feed-forward loop between ROS and p62 contributes to this process; in
particular, excessive ROS induces p62 expression while, in turn, en-
forced p62 expression induces ROS production as part of an amplifying
loop, thereby promoting genome instability. Besides the demonstration
that induction of autophagic response in 27-OH treated cells was ROS-
dependent, of note autophagy modulation by chemical inhibitor and
inducers in turn was able to regulate ROS levels.
As mentioned in the Introduction, the redox-sensitive transcription
factor Nrf2 and autophagy are both involved in oxidative stress re-
sponse to antagonize cellular stressing signals by promoting a series of
antioxidant programs. In fact, as shown in Fig. 5, both p62 and Nrf2
synthesis as we expected were abrogated by mTOR inhibitor Torin 1. It
can be suggested that, in response to oxidative stress, autophagy and
Nrf2 would be in negative interaction with each other, in particular if
Nrf2 antioxidant pathways is suppressed, the further activation of
autophagy is required to reduce ROS accumulation to ensure adaptive
cell survival. Consistently, suppression of autophagy at particular stages
with different inhibitors enhanced Nrf2 expression and nuclear trans-
location upon ROS stimulation in pancreatic cancer cells [57]. Certainly
all results obtained by using inhibitors should be taken with caution.
Hence, all our data concerning the modulation of Nrf2 via autophagy
are fully consistent among them and further indirectly validated by
using both Nrf2 siRNA and antibody (Fig. 6).
Taken together, these data suggest that autophagic responses in-
duced by 27-OH could be associated, in part, to Nrf2 antioxidant re-
sponse which stimulates autophagy via p62 protein and promotes cell
survival during oxidative stress. Emerging studies pointed that under-
standing the relationship between the Nrf2 pathway and autophagy will
advance our knowledge of the progression of oxidative stress-related
diseases. Namely, Nrf2 pathway is induced in response to pro-oxidant
stimuli that up-regulated p62 expression which can further promote
autophagy to protect cells from oxidative damage.
To summarize, our data support the hypothesis that in 27-OH
treated cells induction of autophagy by low concentrations of the
oxysterol is required for the cell survival, as well as for the induction of
cytoprotective responses, i.e. stimulation of Nrf2 antioxidant response
(graphical abstract). Notably, autophagy induced by 27-OH is, in part,
mediated by oxidative stress and that an increase in intracellular ROS is
quenched by activated survival signals including redox-sensitive Nrf2.
Both mitochondrial depolarization and Nox-2 activity contribute to the
pro-oxidant effect of the oxysterol. Moreover, 27-OH-induced MEK/
Fig. 6. The relation between p62 and Nrf2 leading to authophagy. U937 cells were transfected with a specific Nrf2 siRNA for 48 h and then incubated with 27-OH
(10 μM) for 6 h (A). Other cells were incubated with 27-OH (10 μM) in the presence of a specific antibody against Nrf2 for 6 h (B) or 48 h (C). Untreated cells were
taken as controls. Each blot is representative of three experiments. Histograms represent mean values ± S.D. of three experiments and they are expressed as
percentage of control value. **p < 0.01 and ***p < 0.001 vs. untreated control group; ##p < 0.01 vs. 27-OH.
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ERK and PI3K/Akt pathways play regulatory role in oxysterol-mediated
pro-survival autophagy. In the current study, we speculated that ROS
plays a key role in autophagy and in the activation of Nrf2 pathway. In
this connection, 27-OH leads to p62 accumulation thus activating Nrf2
pathway, while the oxysterol pro-oxidant effect activates Nrf2 pathway
against the intracellular ROS generation. It can be suggested that au-
tophagy and Nrf2 activation might function as a adaptive survival re-
sponse and resistance mechanism against the previously established
pro-apoptotic action of 27-OH [19] to delay macrophage apoptosis that
favor growth and destabilization of advanced atherosclerotic plaques
[58]. Further studies are needed to assess the interplay between au-
tophagy and apoptosis in our proposed model. Since both Nrf2 and
autophagy contribute to the chemoresistance, and the interplay be-
tween cell death pathways and autophagy has important pathophy-
siological consequences, developing therapeutic interventions to target
these crosstalks are exciting prospects for future studies.
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